HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS).

Abstract
The symposium "New criteria of resectability for pancreatic cancer" was held during the 33nd meeting of the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) in 2021 to discuss the potential modifications that could be made in the current resectability classification. The meeting focused on setting the foundation for developing a new prognosis-based resectability classification that is based on the tumor biology and the response to neoadjuvant treatment (NAT). The symposium included selected experts from Western and Eastern high-volume centers who have discussed their concept of resectability status through published literature. During the symposium, presenters reported new resectability classifications from their respective institutions based on tumor biology, conditional status, pathology, and genetics, in addition to anatomical tumor involvement. Interestingly, experts from all the centers reached the agreement that anatomy alone is insufficient to define resectability in the current era of effective NAT. On behalf of the JSHBPS, we would like to summarize the content of the conference in this position paper. We also invite global experts as internal reviewers of this paper for intercontinental cooperation in creating an up-to-date, prognosis-based resectability classification that reflects the trends of contemporary clinical practice.
AuthorsAtsushi Oba, Marco Del Chiaro, Sohei Satoi, Sun-Whe Kim, Hidenori Takahashi, Jun Yu, Masayoshi Hioki, Masayuki Tanaka, Yoshiyasu Kato, Kyohei Ariake, Y H Andrew Wu, Yosuke Inoue, Yu Takahashi, Thilo Hackert, Christopher L Wolfgang, Marc G Besselink, Richard D Schulick, Yuichi Nagakawa, Shuji Isaji, Akihiko Tsuchida, Itaru Endo
JournalJournal of hepato-biliary-pancreatic sciences (J Hepatobiliary Pancreat Sci) Vol. 29 Issue 7 Pg. 725-731 (Jul 2022) ISSN: 1868-6982 [Electronic] Japan
PMID34581016 (Publication Type: Journal Article)
Copyright© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Topics
  • Biliary Tract Surgical Procedures
  • Humans
  • Japan
  • Neoadjuvant Therapy
  • Pancreatic Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: